Burbank, CA

Andre Chan

Lion Heart Clinical Research

Diabetic Foot

Royal Biologics

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This study will evaluate a cellular, acellular, matrix-like product (CAMP) and Standard of Care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs). The study will evaluate Amnio-Maxx® Dual Layer Amnion Patch.

Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.

Lion Heart Clinical Research | Burbank, CA

Site insights

Contact this site

Active trials

Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.

Trial sponsors